PRECLINICAL STUDIES WITH IMMUNOCONJUGATES

被引：0

作者：

PIETERSZ, GA

SMYTH, MJ

KANELLOS, J

CUNNINGHAM, Z

MCKENZIE, IFC

机构：

来源：

COVALENTLY MODIFIED ANTIGENS AND ANTIBODIES IN DIAGNOSIS AND THERAPY | 1989年 / 2卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：73 / 97

页数：25

共 50 条

[31] PRECLINICAL TOXICITY STUDIES OF ENALAPRIL
MURN, M
SALOM, L
[J]. ZDRAVSTVENI VESTNIK, 1991, 60 (06): : 263 - 266
[32] PRECLINICAL STUDIES OF CISPLATIN ANALOGS
PRATESI, G
[J]. INORGANICA CHIMICA ACTA-BIOINORGANIC CHEMISTRY, 1987, 137 (1-2): : 35 - 38
[33] Preclinical and clinical studies on motilin
黄裕新
许才绂
冯英明
廖洪
张少玲
王庆莉
[J]. Military Medical Research, 1993, (04) : 410 - 416
[34] PRECLINICAL TOXICOLOGIC STUDIES WITH TOBRAMYCIN
WELLES, JS
GIBSON, WR
ANDERSON, RC
EMMERSON, JL
OWEN, NV
NICKANDE.R
[J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 1972, 22 (02) : 332 - &
[35] PRECLINICAL PHARMACOLOGICAL STUDIES WITH NIMESULIDE
SWINGLE, KF
MOORE, GGI
[J]. DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 1984, 10 (8-9) : 587 - 597
[36] Preclinical studies for antiangiogenesis therapy
Morini, M
Bisacchi, D
Orengo, G
Arena, G
Benelli, R
Garbisa, S
De Flora, S
Noonan, D
Albini, A
[J]. ANNALS OF ONCOLOGY, 2000, 11 : 17 - 17
[37] Capecitabine: Preclinical Pharmacology Studies
Hideo Ishitsuka
[J]. Investigational New Drugs, 2000, 18 : 343 - 354
[38] Design preclinical studies for reproducibility
不详
[J]. NATURE BIOMEDICAL ENGINEERING, 2018, 2 (11): : 789 - 790
[39] Capecitabine: preclinical pharmacology studies
Ishitsuka, H
[J]. INVESTIGATIONAL NEW DRUGS, 2000, 18 (04) : 343 - 354
[40] Design preclinical studies for reproducibility
[J]. Nature Biomedical Engineering, 2018, 2 : 789 - 790